WIPO logo
Мобильная версия | Deutsch | English | Español | Français | 日本語 | 한국어 | Português | 中文 | العربية |
PATENTSCOPE

Поиск по международным и национальным патентным фондам
World Intellectual Property Organization
Поиск
 
Просмотреть
 
Перевод
 
Настройки
 
Новости
 
Войти в систему
 
Помощь
 
Автоматизированный перевод
1. (WO2002026834) 32624 A NOVEL HUMAN UDP-GLUCURONOSYL AND GLYCOSYL TRANSFERASE FAMILY MEMBER AND USES THEREOF
Новейшие библиограф. данные, касающиеся досье в Международном бюро   

TranslationПеревести: оригинал-->русский
№ публикации:    WO/2002/026834    № международной заявки:    PCT/US2001/029963
Дата публикации: 04.04.2002 Дата международной подачи: 25.09.2001
Требованиe в соответствии с Главой 2 подано:    22.04.2002    
МПК:
C12N 9/10 (2006.01), C12Q 1/68 (2006.01)
Заявители: MILLENNIUM PHARMACEUTICALS INC. [US/US]; 75 Sidney Street, Cambridge, MA 02139-4169 (US) (For All Designated States Except US).
LEIBY, Kevin, R. [US/US]; (US) (For US Only)
Изобретатели: LEIBY, Kevin, R.; (US)
Дата приоритета:
60/235,044 25.09.2000 US
Название (EN) 32624 A NOVEL HUMAN UDP-GLUCURONOSYL AND GLYCOSYL TRANSFERASE FAMILY MEMBER AND USES THEREOF
(FR) ELEMENT DE LA FAMILLE DE UDP-GLUCURONOSYLE ET GLYCOSYLE TRANSFERASE HUMAINE, 32624, ET UTILISATIONS CORRESPONDANTES
Реферат: front page image
(EN)The invention provides isolated nucleic acids molecules, designated 32624 nucleic acid molecules, which encode novel UDP-glucuronosyl and plycosyl transferase members. The invention also provides antisense nucleic acids molecules, recombinant expression vectors containing 32624 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 32624 gene has been introduced or disrupted. The invention still further provides isolated 32624 proteins, fusion proteins, antigenic peptides and anti-32624 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
(FR)L'invention concerne des molécules d'acides nucléiques isolées, appelées molécules d'acides nucléiques 32624, qui codent des nouveaux éléments de UDP-glucuronosyle et glycosyle transférase. Cette invention a également des molécules d'acides nucléiques antisens, des vecteurs d'expression recombinante renfermant des molécules d'acides nucléiques 32624, des cellules hôtes dans lesquelles on a introduit des vecteurs d'expression, et des animaux transgéniques non humains chez lesquels on a introduit ou interrompu un gène 32624. Ladite invention concerne, en outre, des protéines 32624 isolées, des protéines hybrides, des peptides antigéniques et des anticorps anti-32624, ainsi que des méthodes diagnostiques utilisant ces compositions.
Указанные государства: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Язык публикации: English (EN)
Язык подачи: English (EN)